Health Care

National spending on health care exceeds $3 trillion per year—almost 18% of GDP—and more than 60% of it was paid by government payors. This has led to a complex commercial, regulatory, and enforcement environment that is in a constant state of flux. Alston & Bird guides you to your goals with a trusted and responsive legal and policy team that can cover every area of your health care business.

A fast-moving and increasingly complex regulatory environment, shifting demographics, and other changes affect your business. As a business leader, you seek opportunities to expand products and services, offer new solutions in the marketplace, and remain competitive. Staying competitive requires sound judgment, knowledge, and agility. Hospitals and health care systems, ancillary care providers, payors, and device and drug manufacturers face challenges that call for responsive counsel who live and breathe the health care industry.

With one of the largest health law practices in the U.S., Alston & Bird offers creative solutions to your legal and business challenges with a cost-efficient approach. With nearly 100 professionals, including lawyers and policy advisors, our team is one of the largest of its kind in the U.S. Our team is fully focused on health care and life sciences, allowing us to quickly spot impending trends, developing rules and regulations, and new technologies that could affect your strategy.

Our team includes a full range of lawyers—regulatory specialists, policy advisors, transactional counsel, and litigators—who are focused entirely on health care. Our transactional team represents health care industry participants across the country in a wide variety of corporate and financial transactions. Their extensive experience in the unique health care commercial and regulatory environment allows them to add value beyond that of typical corporate counsel. Our health care litigators include seasoned veterans who served in the DOJ. In addition, our team includes one of the largest health policy practices in the country with former Administration and congressional officials and staffers lending an inside perspective on the Hill and Executive Branch as well as FDA regulatory issues, investigations, and policy matters.

Highlights

Digital Transformation of Health Care

                                Alston & Bird works with clients on the forefront of the digital transformation of health care. 
                            

Learn More

                        Publications

                        A&B Healthcare Week in Review
                    
                            A weekly publication of Alston & Bird’s health care team providing insight on all things related to health care—from regulations to legislative, from reports to news and events.

Reproductive Health Care Task Force

                        Press Release

                        January 28, 2022

                        Alston & Bird Adds Former FDA Associate Chief Counsel Alexandra Marzelli as Counsel in Washington, D.C.
                    
                            Alston & Bird has expanded its health care and life sciences regulatory and compliance capabilities with the addition of counsel Alexandra Marzelli, former associate chief counsel at the U.S. Food and Drug Administration (FDA). Based in the firm’s Washington, D.C. office, Marzelli joins Alston & Bird’s Health Care and FDA/Food, Drug & Device Groups, where she will advise clients on the FDA’s complex approval process and regulatory compliance for prescription and over-the-counter drugs, biologics, medical devices, food ingredients, and other products regulated by the agency.

Health Care